DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [MDA]
Ontology highlight
ABSTRACT: DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [MDA]
PROVIDER: PRJNA966202 | ENA |
REPOSITORIES: ENA
ACCESS DATA